Under the new program, Medicare enrollees will be eligible to receive one of three drugs Foundayo (the new once-a-day tablet), Wegovy, or Zepbound for weight loss specifically
Clinical studies have demonstrated that these medications can produce additional weight loss in post-bariatric patients who have experienced weight regain or inadequate initial weight loss
TRACK YOUR GLP-1 ROUTINE: - Log your shot timely with smart reminders - Follow prescribed titration and dosing schedules - History of shots - dose, timing, injection sites - See estimated medication activity between doses - Monitor your weight loss progress at every dosage - Use the daily check-in to track cravings, mood, energy, bowel movements, and sleep quality - Analyze the response of each dose by tracking food noise and hunger levels - Smart injection site rotation - Side effects tracking and notes SCIENCE-BACKED SUPPORT - Weekly progress reports to review with your healthcare provider - Explore how your weight loss aligns with reported outcomes in clinical studies - Lifestyle recommendations grounded in official guidelines from the American Society for Nutrition (ASN), American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association - Wisdom feature searches clinical trials and peer-reviewed research to answer your GLP-1 questions, backed by real science REFILL AND SUPPLY TRACKING - Keep your full inventory: vials, pens, concentration, volume, and expiration dates (BUD)
People recovering from injury or surgery, active individuals with nagging aches, and anyone whose recovery feels slower than it used to
Unlike cosmetic anti-aging peptides targeting surface symptoms, Epithalon's telomerase activation addresses a fundamental aging mechanism with potential for true longevity extension beyond mere appearance improvement
